Example: Heart Attack

Search clinical trials for: Machine learning algorithm

Total 10000 results

NCT02907567

Completed

Clinical Trial of CT1812 in Mild to Moderate Alzheimer's Disease

Alzheimer's Disease
NCT00268996

Completed

Integrated Biomarker And Imaging Study - 2

Atherosclerosis
NCT02653495

Terminated

Impact of Metabolic Syndrome on Flu Vaccine Efficacy

Metabolic Syndrome | Immune Deficiency
NCT00363870

Completed

A Study to Demonstrate the Efficacy of GSK Biologicals' Influenza Vaccine in Adults

Influenza
NCT03057340

Unknown

The Treatment of Advanced Lung Cancer With Dribbles Antigen by Targeting Activation of Tcells

Carcinoma, Non-Small-Cell Lung
NCT00408395

Completed

Safety and Immunogenicity of 2 Commercially Available Influenza Vaccines in Children

Influenza
NCT00334334

Completed

Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' 10-valent Pneumococcal Conjugate Vaccine.

Infections, Streptococcal
NCT00338351

Completed

Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' 10-valent Pneumococcal Conjugate Vaccine.

Hepatitis A
NCT00383903

Completed

Evaluate Safety & Immunogenicity of 2 or 3 Doses of GSK HRV Vaccine in Healthy Infants in South Africa

Infections, Rotavirus
NCT00196950

Completed

Study to Evaluate Meningococcal Serogroups A,C,W-135,Y Conjugate Vaccine When Given as 1 Dose to Healthy Subjects Aged 18-25 Years

Infections, Meningococcal
NCT02596308

Completed

Immunogenicity and Safety of Subunit Plague Vaccine

Plague
NCT02339896

Unknown

Observation Study an Immunogenicity Modified TRC-ID Regimen With CPRV With or Without Rabies Immunoglobulin in Children

Dog Bite
NCT02276625

Unknown

One-visit Multi-site Intradermal Rabies Vaccination - Dose Finding

Rabies Pre-exposure Prophylaxis
NCT01486355

Unknown

Additional Measles Vaccine at 4 Months of Age

Measles Infection
NCT01474720

Completed

Zostavax in Systemic Lupus Erythematosus

Systemic Lupus Erythematosus
NCT01489345

Completed

Multiple-Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ONO-2952 in Healthy Adult Subjects

Healthy
NCT00168571

Completed

Long-term Follow-up of Measles Antibodies

Measles
NCT00159055

Withdrawn

Adoptive Immunotherapy for CMV Disease

CMV Disease
NCT00026611

Completed

A Study of Dryvax Vaccine Against Smallpox in Previously Unvaccinated Adults

Smallpox
NCT00037713

Completed

Survival in a Randomized Phase III Trial in Patients With Limited Disease (LD) Small Cell Lung Cancer Vaccinated With Adjuvant BEC2 and BCG

Carcinoma, Small Cell Lung
NCT00316615

Completed

Safety and Immunogenicity of a Inactivated Influenza Vaccine When Administered to Non Elderly Adults and Elderly Subjects.

Influenza Disease
NCT00316628

Completed

Safety and Immunogenicity of an Adjuvanted Influenza Vaccine in Subjects Aged 65 Years and Over.

Influenza
NCT06134648

Completed

Study of a Respiratory Syncytial Virus/Human Metapneumovirus Vaccine Candidate

Healthy Volunteers | Respiratory Syncytial Virus Infection | Human Metapneumovirus
NCT05815264

Completed

Clinical Trial of 23-valent Pneumococcal Polysaccharide Vaccine in Healthy Chinese Population Aged 2 Years and Above

Pneumonia
NCT06151288

Completed

Safety, Tolerability, and Immunogenicity Study of a 31-Valent Pneumococcal Conjugate Vaccine (VAX-31) in Adults

Pneumococcal Vaccines
NCT02927873

Completed

A Study to Evaluate Safety, Reactogenicity and Immunogenicity of GSK Biologicals' RSV Investigational Vaccine Based on Viral Proteins Encoded by Chimpanzee-derived Adenovector (ChAd155-RSV) (GSK3389245A) in RSV-seropositive Infants

Respiratory Syncytial Virus Infections
NCT01991587

Completed

Safety, Tolerability and Immunogenicity of a Plant-made Seasonal Quadrivalent VLP Influenza Vaccine in Adults

RNA Virus Infections | Virus Diseases | Respiratory Tract Infections | Respiratory Tract Diseases
NCT02233816

Completed

Immunogenicity, Safety and Tolerability of a Plant-Derived Seasonal Virus-Like-Particle Quadrivalent Influenza Vaccine in Adults

RNA Virus Infections | Virus Diseases | Respiratory Tract Infections | Respiratory Tract Diseases
NCT01910519

Completed

Systems Biology of Influenza A (H5N1) Virus Monovalent Vaccine With and Without Adjuvant System 03 (AS03)

Influenza A Virus, H5N1 Subtype
NCT00348387

Completed

Immunogenicity and Safety of Imovax Polio in Chinese Infants Compared to Local OPV

Poliomyelitis | Polio
NCT01399853

Completed

A Phase II Clinical Trial for Inactivated Vaccine (Vero Cell) Against EV71 in Chinese Children and Infants

Safety | Immunogenicity
NCT00488826

Completed

Study Evaluating 7-Valent Pneumococcal Conjugate Vaccine in Healthy Infants

Pneumococcal Infections
NCT06765525

Not yet recruiting

Efficacy Study of DeepDDH System in Screening Infants with Developmental Dysplasia of the Hip (DDH)

Hip Dysplasia, Developmental
NCT04789616

Recruiting

The Canadian Maraviroc Randomized Controlled Trial To Augment Rehabilitation Outcomes After Stroke (CAMAROS)

Stroke
NCT01875848

Terminated

Buprenorphine vs. Opioid Dose Escalation Among Patients With Chronic Pain (Bup)

Pain
NCT07242092

Not yet recruiting

Influence of Methotrexate Discontinuation on Immunogenicity After PCV-20 Vaccine in Patients ARDs (MTX-PCV20-ARD)

Autoimmune Rheumatic Diseases
NCT06521944

Recruiting

RSV Vaccine Pregnancy Registry (RSV-PR)

Respiratory Syncytial Virus (RSV)
NCT05540522

Completed

A Study to Evaluate a Modified RNA Vaccine Against Influenza in Adults 18 Years of Age or Older

Influenza, Human
NCT04884308

Completed

Bacille Calmette-Guerin (BCG) Vaccine for Immune Protection Against Infections

Cystic Fibrosis | Bronchiectasis Adult | Non-Tuberculous Mycobacteria
NCT05301322

Completed

Safety and Immunogenicity of RSVpreF Coadministered With SIIV in Adults ≥65 Years of Age

Respiratory Syncytial Virus
NCT05567471

Completed

Phase 3 Study to Evaluate Immunogenicity and Safety of BBV154 Booster Dose

COVID-19 Respiratory Infection
NCT03308825

Completed

Safety and Immunogenicity of Fluzone® Quadrivalent and Fluzone® High-Dose, Influenza Vaccines

Influenza | Flu
NCT03390166

Completed

Immunogenicity and Safety of Tri Fluvac, a Seasonal Trivalent Inactivated Influenza Vaccine in Healthy Thai Adults

Influenza
NCT01735006

Completed

Efficacy and Immunogenicity Study of Recombinant Human Papillomavirus Bivalent（Type 16/18 ）Vaccine

Cervical Cancer | Cervical Intraepithelial Neoplasia | Vaginal Intraepithelial Neoplasia | Vulvar Intraepithelial Neoplasia | Persistent Infection
NCT01196988

Completed

Immunogenicity and Safety Study of GSK Biologicals' Influenza Vaccine When Administered in Children

Influenza
NCT02169583

Completed

Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Repeat Escalating Doses of GSK1325756 Solution for Infusion, and Absolute Bioavailability Relative of an Oral Dose, in Healthy Adult Subjects

Infections, Respiratory Tract
NCT02259608

Completed

γ-irradiated BCG to Train Innate Immunity

Innate Immune Response
NCT01459198

Completed

Evaluating the Safety and Immune Response to a Respiratory Syncytial Virus (RSV) Vaccine in Adults, RSV-Seropositive Children, and RSV-Seronegative Infants and Children

Respiratory Syncytial Virus Infections
NCT01445743

Completed

Immunogenicity and Safety of an Acellular DPT Vaccine During Pregnancy

Pregnancy
NCT01561768

Completed

A Study to Evaluate the Immune Response and Safety of a Seasonal Virus-Like Particle Influenza Vaccine in Healthy Young Adults

Influenza

Search clinical trials for: Machine learning algorithm

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations